References
- Frohlich E D., Tarazi R C., Dustan H P. Hyperdynamic β-adreneroic circulatory state. Arch Intern Med. 1969; 123: 1–7
- Lund-Johansen P. Hemodynamic alteration in hypertension - spontaneous changes and effects of drug therapy. Acta Med Scand Suppl. 1977; 603: 1–14
- Ferrario C M., Page I H., McCubbin J W. Increased cardiac output as a contributory factor in experimental renal hypertension in dogs. Circ Res. 1970; 27: 799–810
- Coleman T G., Guyton A C. Hypertension caused by salt loading in the dog. III. Onset transient of cardiac output and other circulatory variables. Circ Res. 1969; 25: 153–160
- Borst J GG, Borst-de Geus A. Hypertension explained by Starling's theory of circulation homeostasis. Lancet. 1963; i: 677–682
- Ledingham J M., Cohen M B. Changes in the extracellular fluid volume and cardiac output during the development of experimental renal hypertension. Canad Med Ass J. 1964; 90: 292–294
- Guyton A C., Coleman T G., Cowley A W., Jr., Scheel K W., Manning R D., Jr., Norman R A., Jr. Arterial pressure regulation overriding dominance of the kidneys in long-term regulation and hypertension. Am J Med. 1972; 52: 584–594
- Coleman T G., Granger H J., Guyton A C. Whole-body circulatory autoregulation and hypertension. Circ Res. 1971; 28–29(suppl II)II-76–87
- Korner P I. Causal and homoeostatic factors in hypertension. Clin Sci. 1982; 63: 5s–26s
- Folkow B. The haemodynamic consequence of adaptive structural changes of the resistance vessels in hypertension. Clin Sci. 1971; 41: 1–12
- Bravo E L., Tarazi R C., Dustan H P. Multifactorial analysis of chronic hypertension by electrolyte-active steroids in trained, unanesthetized dogs. Circ Res. 1977; 40(suppl I)I-140–145
- Kim K E., Onesti G, DelGuercio E T., Greco J, Fernandes M, Eidelson B. Sequential hemodynamic changes in end-stage renal disease and the anephric state during volume expansion. Hypertension. 1980; 2: 102–110
- Blaustein M P. The interrelation between sodium and calcium fluxes across cell membranes. Rev Physiol Pharmacol. 1974; 70: 33–82
- Haddy F J. Natriuretic hormone - the missing link in low renin hypertension?. Biochem Pharmacol. 1982; 31: 3159–3161
- De Wardener H E., MacGregor G A. The natriuretic hormone and hypertension. J Chron Dis. 1981; 34: 233–248
- Conway J. Hemodynamic consequences of induced changes in blood volume. Circ Res. 1965; 18: 190–198
- Yamatodani A, Wada H. Automated analysis for plasma epinephrine and norepinephrine by liquid chromatography, including a sample cleanup procedure. Clin Chem. 1981; 27: 1983–1987
- Iinuma K, Ikeda I, Ogihara T, Hara H, Shima J, Kurata K, Kumahara Y. Radioimmunoassay of atrial natriuretic polypeptide in plasma with heat treatment. Clin Chem.
- Fletcher P J., Korner P I., Angus J A., Oliver J R. Changes in cardiac output and total peripheral resistance during development of renal hypertension in the rabbit. Lack of conformity with the autoregulation theory. Circ Res. 1976; 39: 633–639
- Korner P I., Oliver J R., Casley D J. Effect of dietary salt on hemodynamics of established renal hypertension in the rabbit. Implication for the autoregulation theory of hypertension. Hypertension. 1980; 2: 794–808
- Denton K M., Anderson W P. Role of angiotensin II in renal wrap hypertension. Hypertension. 1985; 7: 893–898
- Mohring J, Mohring V, Petri M, Haack D. Vasopressor role of ADH in the pathogenesis of malignant DOC hypertension. Am J Physiol. 1977; 232 F260–F269
- Crofton J T., Share L, Shade R E., Lee-Kwon W J., Manning M, Sawyr W H. The importance of vasopressin in the development and maintenance of DOC-salt hypertension in the rat. Hypertension. 1979; 1: 31–38
- Reid J L., Zivin J A., Copin I J. Central and peripheral adrenergic mechanisms in the development of deoxycorticosteronesaline hypertension in rats. Circ Res. 1975; 37: 569–579
- Berecek K H., Murray R D., Gross F. Significance of sodium, sympathetic innervation, tad central adrenergic structures on renal vascular responsiveness in DOCA-treated rats. Circ Res 1980; 47: 675–68
- De Champlain J, Farley L, Cousineau D, Van Araeringen M- R. Circulating catecholamine levels in human and experimental hypertension. Circ Res. 1976; 38: 109–114
- FiLep J, Frolich J C., Fejes-Toth G. Evidence against a vasopressor role of ADH in malignant DOC-salt hypertension. Clin Exp Hypertension. 1985; 7(10)1457–1470
- Dietz R, Schomig A, Rascher W, Strasser R, Bowin J, Ganten U, Kubler W. Contribution of the sympathetic nervous system to the hypertensive effect of a high sodium diet in stroke-prone spontaneously hypertensive rats. Hypertension. 1982; 4: 773–781
- Andersson B, Eriksson L, Fernandez O, Kolmodin C G., Oltner R. Centrally mediated effects of sodium and angiotensin II on arterial blood pressure and fluid balance. Acta Physiol Scand. 1972; 85: 398–407
- Atarashi K, Mulrow P J., Franco-Sanz R, Snajdar R, Rapp J. Inhibition of aldosterone production by an atrial extract. Science 1984; 224: 992–994
- Baum D, Halter J B., Taborsky G J., Jr., Porte D, Jr. Pentobarbital effects on plasma catecholamine: temperature, heart rate, and blood pressure. Am J Physiol. 1985; 248: E95–KXL
- Jandhyala B S., Horn G. Effects of acute blood volume expansion on vascular resistance and reactivity in anaesthetized dogs. Clin Sci. 1983; 65: 9–17